COVID-19 could affect the availability and cost of antiretroviral medicines, but the risks can be mitigated

Child having his antiretroviral medicine administered by his grandmother. Mozambique, 2020. Credit: UNAIDS

UNAIDS study shows that the impact on production and logistics caused by COVID-19 could have a significant effect on antiretroviral therapy supply worldwide, but steps taken now could lessen the damage done

GENEVA, 22 June 2020— A new analysis by UNAIDS has revealed the potential impacts that the COVID-19 pandemic could have in low- and middle-income countries around the world on supplies of the generic antiretroviral medicines used to treat HIV.

antiretroviral drugs, drug shortages, COVID-19